Need professional-grade analysis? Visit stockanalysis.com
$2.54B
N/A
N/A
N/A
Price Chart
Risk-Adjusted Performance
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (301126) Price Performance
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (301126) trades on SHE in CNY. The company is classified in the Healthcare sector under the Pharmaceutical Retailers industry. The stock currently trades at CNY11.07, down 1.60% from the previous close.
Over the past year, 301126 has traded between a low of CNY9.22 and a high of CNY14.35. The stock has lost 4.7% over this period. It is currently 22.9% below its 52-week high.
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd has a market capitalization of $2.54B.
About Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd engages in the wholesale and retail of pharmaceuticals products in China. It provides raw materials, biological products, chemical drugs, Chinese herbal medicines, medical devices, and other products. The company also offers Chinese patent medicines in the form of granules, capsules, particles, tablets, slices, and pills; foods, such as beverages, drinks, and probiotic beverages; and cleansing and care products. In addition, it provides pharmaceutical logistics services; and operates reproductive hospitals. The company was formerly known as Hunan Tongjian Pharmacy CO., LTD and changed its name to Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd in August 2016. Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd was founded in 2002 and is headquartered in Changsha, China.
Company Info
- Sector
- Healthcare
- Industry
- Pharmaceutical Retailers
- Exchange
- SHE
- Currency
- CNY
- Country
- China
Financial Metrics
- Revenue (TTM)
- N/A
- EBITDA
- N/A
- Profit Margin
- N/A
- EPS (TTM)
- N/A
- Book Value
- N/A
Technical Indicators
- 52 Week High
- CN¥14.87
- 52 Week Low
- CN¥8.63
- 50 Day MA
- CN¥12.78
- 200 Day MA
- CN¥12.14
- Beta
- N/A
Valuation
- Trailing P/E
- N/A
- Forward P/E
- N/A
- Price/Sales
- N/A
- Price/Book
- N/A
- Enterprise Value
- $2.54B